BioPoly® Appoints new Vice President of Sales and Marketing
February 16, 2023
FORT WAYNE, IN - BioPoly LLC announced today that Justin J. Kaler has joined the executive management team as the Vice President of Sales and Marketing. An experienced sales and marketing leader, Justin will be assuming responsibilities of this role and focusing efforts on commercialization of its proprietary BioPoly material technology in the United States.
BioPoly® Announces Reformulation of Board, Three New Board Members
January 19, 2023
FORT WAYNE, IN – BioPoly LLC announced today that it has reformulated its board of directors as part of its new strategy and go-forward plan. The new board members have joined the company as acting directors as of January 1, 2023 and have already made significant contributions to the organization.
BioPoly® Announces FDA Clearance of Its Lesser Toe Implant
December 15, 2022
FORT WAYNE, IN – BioPoly LLC has announced that the U.S. Food and Drug Administration has granted clearance for its BioPoly® Lesser Toe System, BioPoly’s second FDA-cleared product in the U.S. market.
BioPoly® Appoints Ryan Schlotterback as New CEO
December 5, 2022
FORT WAYNE, IN – BioPoly LLC announced today that Ryan Schlotterback has joined the executive management team as the President and Chief Executive Officer. An experienced business leader, Ryan, has succeeded Herb Schwartz and has assumed responsibilities of this role.
First BioPoly® Great Toe Surgery Performed in US
October 1, 2021
BioPoly LLC has announced that the first BioPoly® Great Toe surgery in the U.S. was completed on September 30, 2021.
BioPoly® Announces FDA Clearance of Its Great Toe Implant
February 3, 2021
BioPoly LLC has announced that the U.S. Food and Drug Administration has granted clearance for its BioPoly® Great Toe Implant. With this FDA clearance, the BioPoly technology is available for the first time in the U.S.